Professor of Vaccinology and Director of the SAMRC Vaccines and Infectious Diseases Analytical Research Unit, University of the Witwatersrand
New COVID-19 data: South Africa has arrived at the recovery stage of the pandemic
Another resurgence is likely, and there might well be another variant
COVID-19 herd immunity? It’s not going to happen, so what next?
The only sustainable solution is to learn to live with the virus.
Results from Novavax vaccine trials in the UK and South Africa differ: why, and does it matter?
The efficacy of the vaccine was 89 per cent in United Kingdom and 60 per cent in South Africa